NCT02749370 Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast Status COMPLETED Phase PHASE4
NCT02742441 A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310) Status COMPLETED Phase PHASE3
NCT02701205 Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis Status UNKNOWN Phase PHASE3
NCT02634801 A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment Status COMPLETED Phase PHASE3
NCT02618759 Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02601469 Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02561806 A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02547714 Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A Status COMPLETED Phase PHASE4
NCT02527421 DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis Status TERMINATED Phase PHASE3
NCT02515097 Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02514577 Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02513550 A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02494479 Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02489227 Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02486302 A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis. Status COMPLETED Phase N/A
NCT02462122 Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02462083 Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02462070 Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02435342 A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis Status COMPLETED Phase PHASE1